News from IrsiCaixa

All the news in a click

The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients

Study shows efficacy of remdesivir in preventing severity of COVID-19 and European Commission extends its use in people at risk

IrsiCaixa and Vall d’Hebron map the HIV reservoir and describe the atlas of cells where the virus is hidden

HIV, new objectives and a story of hope

Use of PrEP in Catalonia could save 93 million euros over the next 40 years

Barcelona CaixaResearch Living Lab, promoting impact research with and for society

More than 20 organisations collaborate as a network to improve the model for promoting healthy and sustainable food in Barcelona

IrsiCaixa is working on the development of synthetic antibodies to prevent SARS-CoV-2 infection thanks to the support of the Gloria Soler Foundation

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: